Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,069,900 | 2,616,900 | 4,582,100 | 3,489,000 | 3,238,000 |
| Marketable Securities | 2,364,200 | 888,700 | 1,456,500 | 737,800 | 696,800 |
| Receivables | 4,956,100 | 4,613,900 | 4,766,300 | 4,521,400 | 4,493,100 |
| Inventories | 4,346,000 | 4,035,100 | 3,561,900 | 3,881,200 | 3,759,900 |
| TOTAL | $15,746,500 | $12,976,200 | $15,101,400 | $13,385,900 | $12,977,300 |
| Non-Current Assets | |||||
| PPE Net | 8,582,800 | 8,425,500 | 8,252,600 | 8,251,900 | 8,066,100 |
| Investments And Advances | 5,723,300 | 5,297,700 | 5,207,500 | 5,027,000 | 4,449,200 |
| Intangibles | 4,542,600 | 4,716,700 | 4,357,900 | 4,638,500 | 4,806,300 |
| Other Non-Current Assets | 6,351,300 | 6,208,200 | 5,886,500 | 6,287,000 | 6,176,400 |
| TOTAL | $25,200,000 | $24,648,100 | $23,704,500 | $24,204,400 | $23,498,000 |
| Total Assets | $40,946,500 | $37,624,300 | $38,805,900 | $37,590,300 | $36,475,300 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,257,200 | 1,220,100 | 1,349,300 | 1,161,200 | 1,207,800 |
| Other current liabilities | 6,809,600 | 6,496,600 | 7,032,700 | 6,287,100 | 5,921,900 |
| TOTAL | $11,294,500 | $10,448,000 | $10,986,600 | $8,272,800 | $8,401,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,867,900 | 7,637,500 | 8,367,800 | 8,707,300 | 8,685,500 |
| Other Non-Current Liabilities | 5,614,400 | 5,435,100 | 5,371,000 | 4,994,400 | 4,732,600 |
| TOTAL | $15,482,300 | $13,072,600 | $13,738,800 | $13,701,700 | $13,418,100 |
| Total Liabilities | $26,776,800 | $23,520,600 | $24,725,400 | $21,974,500 | $21,819,100 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,100,989 | 1,103,389 | 1,103,352 | 1,103,948 | 1,103,843 |
| Common Shares | 688,500 | 690,000 | 688,500 | 690,400 | 690,300 |
| Retained earnings | 15,590,100 | 15,876,700 | 16,046,300 | 16,601,600 | 15,824,100 |
| Other shareholders' equity | -7,719,000 | -8,004,600 | -8,213,900 | -7,243,800 | -7,365,000 |
| TOTAL | $14,169,700 | $14,103,700 | $14,080,500 | $15,615,800 | $14,656,200 |
| Total Liabilities And Equity | $40,946,500 | $37,624,300 | $38,805,900 | $37,590,300 | $36,475,300 |